Helsinn announces abstract accepted for oral presentation at the EORTC Cutaneous Lymphoma Meeting 2019

NEXT STORY
EyePoint Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
PREV STORY
Treos Bio Reports Updated Positive Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

IMMUNEERING EXPANDS ONCOLOGY SCIENTIFIC ADVISORY BOARD WITH EXPERTS IN KEY CANCER SIGNALING PATHWAY

author_avatar
NASDAQ Market News

Cytokinetics Reports Third Quarter 2019 Financial Results

author_avatar
NASDAQ Market News

CK Hutchison prices offering of Chi-Med share capital enabling deconsolidation and confirms its intention to hold Chi-Med as a strategic investment for the long term

author_avatar
NASDAQ Market News